News & Content

Xaira Therapeutics Announces the Appointment of Dr. Paulo Fontoura as Chief Medical Officer and Dr. Hetu Kamisetty as Chief Technology Officer

AI enters a new phase, and the Fortune 50 AI Innovators list identifies the companies leading it

Xaira Therapeutics Appoints Dr. Debbie Law as Chief Scientific Officer and Julia Tran as Chief People Officer

Endpoints 11 winner Xaira Therapeutics: Biotech’s largest AI bet with A-list backers

Designed endocytosis-inducing proteins degrade targets and amplify signals

LinkedIn Top Startups 2024: The 50 U.S. companies on the rise

Inside the Seattle labs of Xaira, the AI-powered startup launched with $1B from investors

Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugs

Exclusive: Marc Tessier-Lavigne on leaving Stanford and joining biotech’s new AI mega-startup

Why VC legend Bob Nelsen is making the biggest initial bet of his 37-year career on Xaira

Press Release: Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for Drug Discovery and Development

Atomically accurate de novo design of single-domain antibodies

Single cell sequencing as a general variant interpretation assay

De novo design of protein structure and function with RFdiffusion

Exclusive: In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D